1. Abe T, Seo T, Ishitsu T, Nakagawa T, Hori M, Nakagawa K (2008) Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. Br J Clin Pharmacol 66:304–307
2. Allen JD, Ekue JM, Shanks RG, Zaidi SA (1972) The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias. Br J Pharmacol 45:561–573
3. Anon (2005) ICH Note for Guidance on “The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs” (ICH E14) (CHMP/ICH/2/04). EMEA, London, 25 May 2005 http://www.emea.eu.int/pdfs/human/ich/000204en.pdf [Accessed on 10 August 2009]
4. Aurlien D, Taubøll E, Gjerstad L (2007) Lamotrigine in idiopathic epilepsy - increased risk of cardiac death? Acta Neurol Scand 115:199–203
5. Aurlien D, Leren TP, Taubøll E, Gjerstad L (2009) New SCN5A mutation in a SUDEP victim with idiopathic epilepsy. Seizure 18:158–160